Investigations on the in vitro release mechanism of sodium alendronate from hydrophilic matrix tablets

Farmacia

Volumn 58, Issue 6, 2010, Pages 795-805

  Ochiuz, Lacrǎmioara ^a   Iulian, Stoleriu ^b   Moscalu, Mihaela ^a   Popa, Graţiela ^a   Adrian, Spac ^a   Popovici, Iuliana ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b ALEXANDRU IOAN CUZA UNIVERSITY OF IASI   (Romania)

Author keywords

Alendronate; Carbopol; Chitosan; Matrix tablets

Indexed keywords

AEROSIL; ALENDRONIC ACID; CARBOMER; CHITOSAN; MAGNESIUM STEARATE; TRIMETHYL CHITOSAN; UNCLASSIFIED DRUG;

ARTICLE; DRUG RELEASE; HYDROPHILICITY; IN VITRO STUDY; MATHEMATICAL MODEL; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET FORMULATION;

EID: 78650710683     PISSN: 00148237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Fleisch, H., Bisphosphonates in bones diseases: from the laboratory to the patient, 4th ed., Academic press, San Diego, 2000, 30
2. Barlt, R., Fisch, B., Von Tresckow, E., Bisphosphonates in medical practice, Springer Berlin Heiddelberg, New York, 2007, 86
3. Favus, M. J., Premier on the metabolic bone diseases and disorders of mineral metabolism, 5th ed., Lippincott, Philadelphia, 2003, 20-25
4. Santini, D., Vespasiani, G., Vincenti, B., The antineoplasic role of bisphosphonates: from basic research to clinical evidence, Ann. Oncol, 14, 2003, 1468
5. Lasseter, K., Porras, A., G., Denker, A., et al., Pharmacokinetic considerations in determining the terminal elimination half-lives of bisphosphonates, Clin Drug Invest, 25, 2005, p. 107
6. Rondeau, J., M., Bitsch, F., Bourgier, E., et al., Structural basis for the exceptional in vivo efficacy of bisphosphonates drugs, Chem Med Chem2006, 1, 2, 267
7. Rosen, C., J., Hochberg, M., Bonnick, S., et al., Treatment with once-weekly alendronate 70 mg compared to once-weekly residronate 35 mg in women with postmenopausal osteoporosis: A randomized double-blind study, J Bone Miner Res, 2005, 20, 141
8. Kikuchi, C., Takayama, K., Multivariate statistical approach to optimizing sustained-release tablets formulations containing diltiazem hydrochloride as a model highly water soluble drug, Int. J. Pharm., 2010, 386, 149-155
9. Ferrero, C., Massuelle, D., Doelker, E., Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis, J. Control. Release, 2010, 141, 223-233
10. *** Controlled Release Tablets and Capsules Bulletin 32, 2008, Lubrizol Inc., U.S.A.
11. Ochiuz, L., Lisa, G., Grigoras, C., Avadanei, M., Gafitanu, E., Thermal stability of sodium alendronate in a mixture with cross-linked acrilic acid polymers and chitosan, Mat. Plast., 2008, 45, 4, 372
12. Ochiuz, L., Popa, G., Gafitanu, E., Development of hydrophilic swellable carbopol matrixes for extended release of alendronate tablets, Farmacia, 2008, 56, 5, 521-531
13. Singla, A., K., Chawla, M., Chitosan: some pharmaceutical and biological aspects - an update, J. Pharm. Pharmacol., 2001, 53, 1047
14. Mahesh, C. Using chitosan as an excipient for oral drug delivery, Drug Deliv. Tech. 2003, 3, 25-32.
15. Ochiuz, L., Peris, J., E., Preparation and characterisation of alendronate-loaded chitosan microparticles obtained through the spray drying technique, Med Chem, 2009, 5, 2, 191
16. *** United States Pharmacopoeia 32, National Formulary 27, New York, 2009, 1013
17. Vijai, K., Divya, T., Dissolution in Remington The Science and Practice of Pharmacy, 21st ed., Lippincott Williams & Wilkins, Maryland, 2006, 687
18. Costa, P., Lobo, J., M., S., Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci., 2001, 13, 123
19. Avachat, A., Kotwal, V., Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate, AAPS Pharm. Sci. Tech, 2007, 8, 4, article 88
20. Saeio, K., Pongpaibul, Y., Viernstein, S., O., Factors influencing drug dissolution characteristic from hydrophilic polymer matrix tablet, Sci. Pharm., 2007, 75, 147.